Bian T, Lynch A, Ballas K, Mamallapalli J, Freeman B, Scala A
ACS Pharmacol Transl Sci. 2024; 7(11):3502-3517.
PMID: 39539272
PMC: 11555507.
DOI: 10.1021/acsptsci.4c00415.
Freeman B, Mamallapalli J, Bian T, Ballas K, Lynch A, Scala A
Int J Mol Sci. 2023; 24(11).
PMID: 37298489
PMC: 10253622.
DOI: 10.3390/ijms24119539.
Xu X, Tian X, Song L, Xie J, Liao J, Meeks J
Biomolecules. 2023; 13(3).
PMID: 36979456
PMC: 10046577.
DOI: 10.3390/biom13030521.
Liu Z, Song L, Xie J, Wu X, Gin G, Wang B
Molecules. 2023; 28(4).
PMID: 36838656
PMC: 9966944.
DOI: 10.3390/molecules28041666.
Xing C, Malaty J, Malham M, Abi Nehme A, Freeman B, Huo Z
Trials. 2023; 24(1):36.
PMID: 36653872
PMC: 9847434.
DOI: 10.1186/s13063-023-07081-x.
Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer.
Song L, Mino M, Yamak J, Nguyen V, Lopez D, Pham V
Front Oncol. 2022; 12:943846.
PMID: 35912174
PMC: 9326116.
DOI: 10.3389/fonc.2022.943846.
An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.
Soares R, Dinis-Oliveira R, Oliveira N
J Clin Med. 2022; 11(14).
PMID: 35887801
PMC: 9315573.
DOI: 10.3390/jcm11144039.
Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice.
Liu Z, Song L, Xie J, Simoneau A, Uchio E, Zi X
Pharmaceutics. 2022; 14(3).
PMID: 35335874
PMC: 8955676.
DOI: 10.3390/pharmaceutics14030496.
Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1.
Li X, Song L, Xu S, Tippin M, Meng S, Xie J
J Transl Genet Genom. 2021; 5:163-172.
PMID: 34368644
PMC: 8341175.
DOI: 10.20517/jtgg.2021.22.
Peppers: A "Hot" Natural Source for Antitumor Compounds.
Cunha M, Tavares M, Fernandes T, Parise-Filho R
Molecules. 2021; 26(6).
PMID: 33802144
PMC: 8002096.
DOI: 10.3390/molecules26061521.
Medicine in motion: Opportunities, challenges and data analytics-based solutions for traditional medicine integration into western medical practice.
Jansen C, Baker J, Kodaira E, Ang L, Bacani A, Aldan J
J Ethnopharmacol. 2020; 267:113477.
PMID: 33098971
PMC: 7577282.
DOI: 10.1016/j.jep.2020.113477.
The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells.
Hseu Y, Chiang Y, Gowrisankar Y, Lin K, Huang S, Shrestha S
Cancers (Basel). 2020; 12(10).
PMID: 33053749
PMC: 7600613.
DOI: 10.3390/cancers12102936.
Kava as a Clinical Nutrient: Promises and Challenges.
Bian T, Corral P, Wang Y, Botello J, Kingston R, Daniels T
Nutrients. 2020; 12(10).
PMID: 33027883
PMC: 7600512.
DOI: 10.3390/nu12103044.
The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers.
Wang Y, Narayanapillai S, Tessier K, Strayer L, Upadhyaya P, Hu Q
Cancer Prev Res (Phila). 2020; 13(5):483-492.
PMID: 32102948
PMC: 7461349.
DOI: 10.1158/1940-6207.CAPR-19-0501.
Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
Hseu Y, Yang T, Li M, Rajendran P, Mathew D, Tsai C
J Cell Mol Med. 2018; 23(2):775-788.
PMID: 30549180
PMC: 6349172.
DOI: 10.1111/jcmm.13973.
Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway.
Liu Z, Ha U, Yu K, Wu C, Yokoyama N, Zi X
J Biomed Res. 2017; 31(5):408-418.
PMID: 28959001
PMC: 5706433.
DOI: 10.7555/JBR.31.20160160.
Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
Abu N, Akhtar M, Yeap S, Lim K, Ho W, Abdullah M
BMC Complement Altern Med. 2016; 16:86.
PMID: 26922065
PMC: 4769841.
DOI: 10.1186/s12906-016-1046-8.
Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich Kava fraction.
Tang S, Zhang J, Jiang P, Datta P, Leitzman P, OSullivan M
Mol Carcinog. 2016; 55(12):2291-2303.
PMID: 26840761
PMC: 6518389.
DOI: 10.1002/mc.22469.
Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X, Yokoyama N, Zhang S, Ding L, Liu H, Lilly M
Oncotarget. 2015; 6(39):41809-24.
PMID: 26497688
PMC: 4747190.
DOI: 10.18632/oncotarget.6166.
Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).
Wanwimolruk S, Phopin K, Prachayasittikul V
EXCLI J. 2015; 13:869-96.
PMID: 26417310
PMC: 4464477.